Comparative Analysis of 2025 American College of Cardiology/American Heart Association/Multisociety and 2023 European Society of Cardiology Acute Coronary Syndrome Guidelines: Implications for Advanced Practice Registered Nurses

This systematic comparative analysis examines the divergent approaches between the 2025 American College of Cardiology (ACC)/American Heart Association (AHA)/Multisociety (ACC/AHA/Multisociety) and the 2023 European Society of Cardiology guidelines for Acute Coronary Syndrome (ACS) management, with specific focus on implications for Advanced Practice Registered Nurses (APRNs). Despite sharing fundamental principles, these guidelines present significant variations in diagnostic thresholds, risk stratification methodologies, pharmacological interventions, and revascularization strategies that directly influence clinical decision-making processes. As APRNs assume increasingly autonomous roles in cardiovascular care delivery across various settings-from emergency departments to rehabilitation services-understanding these nuanced differences becomes essential for implementing evidence-based practice. This analysis methodically evaluates guideline variations across six domains: diagnostic criteria evolution, risk assessment tools, pharmacological management updates, interventional approaches, secondary prevention recommendations, and technological integration. Each section provides actionable recommendations for translating guideline updates into APRN practice while acknowledging jurisdictional variations in scope of practice. By elucidating these comparative differences, this analysis aims to enhance APRN clinical competency in navigating potentially conflicting international recommendations, ultimately optimizing patient-centered care delivery in accordance with the most current evidence-based standards in ACS management.